These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 34991886)

  • 1. LRRK2 and idiopathic Parkinson's disease.
    Rocha EM; Keeney MT; Di Maio R; De Miranda BR; Greenamyre JT
    Trends Neurosci; 2022 Mar; 45(3):224-236. PubMed ID: 34991886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 activation in idiopathic Parkinson's disease.
    Di Maio R; Hoffman EK; Rocha EM; Keeney MT; Sanders LH; De Miranda BR; Zharikov A; Van Laar A; Stepan AF; Lanz TA; Kofler JK; Burton EA; Alessi DR; Hastings TG; Greenamyre JT
    Sci Transl Med; 2018 Jul; 10(451):. PubMed ID: 30045977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.
    Pang SY; Lo RCN; Ho PW; Liu HF; Chang EES; Leung CT; Malki Y; Choi ZY; Wong WY; Kung MH; Ramsden DB; Ho SL
    Transl Neurodegener; 2022 Jan; 11(1):5. PubMed ID: 35101134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease.
    Taylor M; Alessi DR
    Curr Opin Cell Biol; 2020 Apr; 63():102-113. PubMed ID: 32036294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
    Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
    J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LRRK2-macroautophagy axis and its relevance to Parkinson's disease.
    Manzoni C
    Biochem Soc Trans; 2017 Feb; 45(1):155-162. PubMed ID: 28202669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants.
    Ilieva NM; Hoffman EK; Ghalib MA; Greenamyre JT; De Miranda BR
    Neurobiol Dis; 2024 Jun; 196():106522. PubMed ID: 38705492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease.
    Rocha EM; De Miranda BR; Castro S; Drolet R; Hatcher NG; Yao L; Smith SM; Keeney MT; Di Maio R; Kofler J; Hastings TG; Greenamyre JT
    Neurobiol Dis; 2020 Feb; 134():104626. PubMed ID: 31618685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble α-synuclein in neurons.
    Schapansky J; Khasnavis S; DeAndrade MP; Nardozzi JD; Falkson SR; Boyd JD; Sanderson JB; Bartels T; Melrose HL; LaVoie MJ
    Neurobiol Dis; 2018 Mar; 111():26-35. PubMed ID: 29246723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.
    Agalliu I; Ortega RA; Luciano MS; Mirelman A; Pont-Sunyer C; Brockmann K; Vilas D; Tolosa E; Berg D; Warø B; Glickman A; Raymond D; Inzelberg R; Ruiz-Martinez J; Mondragon E; Friedman E; Hassin-Baer S; Alcalay RN; Mejia-Santana H; Aasly J; Foroud T; Marder K; Giladi N; Bressman S; Saunders-Pullman R
    Mov Disord; 2019 Sep; 34(9):1392-1398. PubMed ID: 31348549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes.
    Wang X; Bondar VV; Davis OB; Maloney MT; Agam M; Chin MY; Cheuk-Nga Ho A; Ghosh R; Leto DE; Joy D; Calvert MEK; Lewcock JW; Di Paolo G; Thorne RG; Sweeney ZK; Henry AG
    Elife; 2023 Oct; 12():. PubMed ID: 37874617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 at the interface of autophagosomes, endosomes and lysosomes.
    Roosen DA; Cookson MR
    Mol Neurodegener; 2016 Dec; 11(1):73. PubMed ID: 27927216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directing LRRK2 to membranes of the endolysosomal pathway triggers RAB phosphorylation and JIP4 recruitment.
    Kluss JH; Bonet-Ponce L; Lewis PA; Cookson MR
    Neurobiol Dis; 2022 Aug; 170():105769. PubMed ID: 35580815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of LRRK2 in Intracellular Organelle Dynamics.
    Boecker CA
    J Mol Biol; 2023 Jun; 435(12):167998. PubMed ID: 36764357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Methods to Analyze LRRK2 Functions Under Lysosomal Stress: The Measurements of Cathepsin Release and Lysosomal Enlargement.
    Sakurai M; Kuwahara T
    Methods Mol Biol; 2021; 2322():63-72. PubMed ID: 34043193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Parkinson's disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress.
    McCarron KR; Elcocks H; Mortiboys H; Urbé S; Clague MJ
    Biochem J; 2024 Feb; 481(4):265-278. PubMed ID: 38299383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 along the Golgi and lysosome connection: a jamming situation.
    Piccoli G; Volta M
    Biochem Soc Trans; 2021 Nov; 49(5):2063-2072. PubMed ID: 34495322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 signaling in neurodegeneration: two decades of progress.
    Iannotta L; Greggio E
    Essays Biochem; 2021 Dec; 65(7):859-872. PubMed ID: 34897411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.